Efficacies and Chemical Structures of Modern Drugs for Hepatitis C Virus Treatment
- Авторы: Kazakov A.S.1, Lepakhin V.K.1, Bukatina T.M.1, Snegireva I.I.1, Zatolochina K.É.2
- 
							Учреждения: 
							- Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- Peoples Friendship University of Russia
 
- Выпуск: Том 52, № 6 (2018)
- Страницы: 497-500
- Раздел: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245278
- DOI: https://doi.org/10.1007/s11094-018-1847-9
- ID: 245278
Цитировать
Аннотация
Hepatitis C virus (HCV) is the leading cause of chronic liver disease, surpassing hepatitis B virus and alcohol. The paradigm for treating HCV has radically changed over the last 20 years. The tolerability and duration of treating HCV patients was altered fundamentally by the emergence of modern and more efficacious treatment regimens and plans. Nevertheless, the risk of developing serious adverse reactions, including those due to drug–drug interactions, remains high. Currently, eight drugs are approved for treating HCV and avoid the use of interferons. The present article reviews these drugs with respect to their efficacy and safety for use in patients with various HCV genotypes.
Ключевые слова
Об авторах
A. Kazakov
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
							Автор, ответственный за переписку.
							Email: a.kazakov15@gmail.com
				                					                																			                												                	Россия, 							8/2 Petrovskii Blvd, Moscow, 127051						
V. Lepakhin
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Россия, 							8/2 Petrovskii Blvd, Moscow, 127051						
T. Bukatina
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Россия, 							8/2 Petrovskii Blvd, Moscow, 127051						
I. Snegireva
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Россия, 							8/2 Petrovskii Blvd, Moscow, 127051						
K. Zatolochina
Peoples Friendship University of Russia
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Россия, 							Moscow, 117198						
Дополнительные файлы
 
				
			 
						 
					 
						 
						 
						 
									 
  
  
  
  
  Отправить статью по E-mail
			Отправить статью по E-mail  Открытый доступ
		                                Открытый доступ Доступ предоставлен
						Доступ предоставлен Только для подписчиков
		                                		                                        Только для подписчиков
		                                					